(P-1217) Validation of Cefiderocol (FDC) Package Insert Dosing Recommendation for Patients receiving Continuous Renal Replacement Therapy (CRRT): A Prospective Multi-Center Pharmacokinetic Study

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Aliaa Fouad, PhD

Infectious Diseases Pharmacotherapy Fellow
Hartford Hospital
Farmington, Connecticut, United States

Emir Kobic, BCIDP

Infectious Diseases Pharmacists
Banner University Medical Center Phoenix
Phoenix, Arizona, United States
NN

Nelson P. Nicolasora, MD

Co-Author
Banner University Medical Center
Phoenix, Arizona, United States
MT

Melissa L. Thompson Bastin, PharmD, PhD

University of Kentucky Medical Center
Lexington, Kentucky, United States
PA

Paul M. Adams, MD

University of Kentucky College of Medicine
Lexington, Kentucky, United States
YS

Yuwei Shen, PharmD

Hartford Hospital
Hartford, Connecticut, United States
AF

Andrew J. Fratoni, PharmD

Associate Director, Clinical and Laboratory Studies
Hartford Hospital
Hartford, Connecticut, United States
XY

Xiaoyi Ye, MD

Hartford Hospital
Hartford, Connecticut, United States
Joseph L. Kuti, PharmD

Associate director
Hartford Hospital
Hartford, CT, United States
DN

David P. Nicolau, PharmD

Director
Hartford Hospital
Hartford, Connecticut, United States
Tomefa E. Asempa, PharmD

Associate Director
Hartford Hospital
Hartford, CT, United States